These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33253326)

  • 1. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.
    Xu X; Ramanujam M; Visvanathan S; Assassi S; Liu Z; Li L
    PLoS One; 2020; 15(11):e0242863. PubMed ID: 33253326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.
    Mahoney JM; Taroni J; Martyanov V; Wood TA; Greene CS; Pioli PA; Hinchcliff ME; Whitfield ML
    PLoS Comput Biol; 2015 Jan; 11(1):e1004005. PubMed ID: 25569146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.
    Assassi S; Swindell WR; Wu M; Tan FD; Khanna D; Furst DE; Tashkin DP; Jahan-Tigh RR; Mayes MD; Gudjonsson JE; Chang JT
    Arthritis Rheumatol; 2015 Nov; 67(11):3016-26. PubMed ID: 26238292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.
    Martyanov V; Whitfield ML
    Curr Opin Rheumatol; 2016 Jan; 28(1):83-8. PubMed ID: 26555452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TLR7, TLR9, JAK2, and STAT3 genes in peripheral blood mononuclear cells from patients with systemic sclerosis.
    Vreća M; Zeković A; Damjanov N; Andjelković M; Ugrin M; Pavlović S; Spasovski V
    J Appl Genet; 2018 Feb; 59(1):59-66. PubMed ID: 29147913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis.
    Franks JM; Toledo DM; Martyanov V; Wang Y; Huang S; Wood TA; Spino C; Chung L; Denton CP; Derrett-Smith E; Gordon JK; Spiera R; Domsic R; Hinchcliff M; Khanna D; Whitfield ML
    Rheumatology (Oxford); 2022 Dec; 62(1):19-28. PubMed ID: 35751592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits.
    Berkowitz JS; Tabib T; Xiao H; Sadej GM; Khanna D; Fuschiotti P; Lafyatis RA; Das J
    Arthritis Rheumatol; 2023 Oct; 75(10):1819-1830. PubMed ID: 37096444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator combinations identify systemic sclerosis patients with more severe disease.
    Wang Y; Franks JM; Yang M; Toledo DM; Wood TA; Hinchcliff M; Whitfield ML
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
    Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
    Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis.
    Hinchcliff M; Huang CC; Wood TA; Matthew Mahoney J; Martyanov V; Bhattacharyya S; Tamaki Z; Lee J; Carns M; Podlusky S; Sirajuddin A; Shah SJ; Chang RW; Lafyatis R; Varga J; Whitfield ML
    J Invest Dermatol; 2013 Aug; 133(8):1979-89. PubMed ID: 23677167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic approach to understanding the pathogenesis of systemic sclerosis.
    Zuo X; Zhang L; Luo H; Li Y; Zhu H
    Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?
    Assassi S; Mayes MD
    Curr Opin Rheumatol; 2013 Nov; 25(6):686-91. PubMed ID: 24061076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.